CLINICAL_TRIALS
trial_result
· 2024-03-18
Clinical Trial Update: Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial [Phase 2]
Summary
Phase 2 randomized trial evaluating vitamin D3 supplementation in low-risk prostate cancer; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-03-18